Show an ad over header. AMP

I am the FIRST!!!

AppHarvest, a Morehead, Ky.-based developer of large-scale tomato greenhouses, is going public

AppHarvest, a Morehead, Ky.-based developer of large-scale tomato greenhouses, is going public via a reverse merger with a SPAC called Novus Capital (Nasdaq: NOVSU). The company would have an initial market value of around $1 billion.

Why it's a BFD: This is about to be a "unicorn" based in one of America's poorest congressional districts. AppHarvest CEO Jonathan Webb tells Axios that the company will employ around 350 people in Morehead by year-end, and that its location allows its product to reach 75% of the continental U.S. within a one-day drive.


  • Details: The merger would include $375 million in new equity commitments from Fidelity, Inclusive Capital, and Novus Capital. AppHarvest previously raised around $160 million in VC funding firms firms like ValueAct Capital, Revolution Rise of the Rest, and Equilibrium Capital.
  • AppHarvest directors include Martha Stewart, J.D. Vance, Jeff Ubben, and Impossible Foods CFO David Lee.
  • The bottom line: “We looked at lots of ag startups, but a lot of time we found a desire to build tech for its own sake without a really good business model or understanding of how to bring the produce to market. But here they already had distribution agreements and were growing produce at scale with defensible margins.” — J.D. Vance, AppHarvest director and early investor, tells Axios

regular 4 post ff

infinite scroll 4 pff

Facebook extends Trump ban indefinitely over incitement of violence

President Trump is banned from posting on his Facebook and Instagram accounts for at least the next two weeks until the transition of power to President-elect Joe Biden is complete, Facebook CEO Mark Zuckerberg wrote in a post Thursday.

Why it matters: It's an extraordinary step for Facebook to take, given that the company has been one of the slowest to take action against the President's account and has historically prioritized free speech, especially for world leaders.

Keep reading...Show less

Podcast: The vaccine pipeline, beyond Pfizer and Moderna

America has become a two-vaccine nation, but plenty of other companies are continuing to work on new vaccines that could increase supply and accelerate the country's goal of herd immunity.

Axios Re:Cap digs into the vaccine pipeline with Derek Lowe, a medicinal chemist and biotech blogger.

Biden team mobilizes to connect Americans to aid in $1.9 trillion rescue plan

President Biden's inner circle has spent a ton of time thinking about how to sell his $1.9 trillion American Rescue Plan around the country — long after he signs it into law this week.

Why it matters: Total opposition from elected Republicans in Washington renders public popularity and bipartisanship across the U.S. vital to maintaining support for the president's agenda.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;